$245.30
-3.18-1.28%
At close: Jul 20, 5:00 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
First Trust Amex Biotech Index Fund (FBT) Stock Price, Quote, News & History
FBTARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
3.24B
Fund Score
Loading...
Key Statistics
Open
$248.89
High
$248.96
52 Wk High
$258.20
AUM
3.24B
Dividend
$4.69
Ex-Div Date
Dec 13, 2024
Volume
16.28K
Market Cap
$26.25B
Mgmt Fee
0.4%
P/E Ratio
24.83
Prev. Close
$248.48
Low
$245.18
52 Wk Low
$158.92
Shares Out
7.55M
Yield
2.24%
Div. Freq
-
Avg. Volume Daily
60.36K
Beta
0.65
Avg. Expense Ratio
0.54%
P/B Ratio
3.61
Recent First Trust NYSE Arca Biotechnology Index Fund News
FAQ
Q
How do I buy First Trust Amex Biotech Index Fund (FBT) stock?
A
You can purchase shares of First Trust Amex Biotech Index Fund (ARCA:FBT) through any online brokerage.
Q
Who are First Trust Amex Biotech Index Fund (FBT) competitors?
A
There are no as such competitors for First Trust Amex Biotech Index Fund.
Q
What is the forecast, or price target, for First Trust Amex Biotech Index Fund (FBT) stock?
A
There is no analysis for First Trust Amex Biotech Index Fund to provide a consensus price target.
Q
What is the current price for First Trust Amex Biotech Index Fund (FBT)?
A
The stock price for First Trust Amex Biotech Index Fund (ARCA: FBT) is $245.3 last updated July 20, 2026 at 6:30 PM EDT.
Q
Does First Trust Amex Biotech Index Fund (FBT) pay a dividend?
A
There are no upcoming dividends for First Trust Amex Biotech Index Fund.
Q
When is First Trust Amex Biotech Index Fund (ARCA:FBT) reporting earnings?
A
First Trust Amex Biotech Index Fund does not have any upcoming earnings scheduled.
Q
Is First Trust Amex Biotech Index Fund (FBT) going to split?
A
There is no upcoming split for First Trust Amex Biotech Index Fund.
Key Statistics
Open
$248.89
High
$248.96
52 Wk High
$258.20
AUM
3.24B
Dividend
$4.69
Ex-Div Date
Dec 13, 2024
Volume
16.28K
Market Cap
$26.25B
Mgmt Fee
0.4%
P/E Ratio
24.83
Prev. Close
$248.48
Low
$245.18
52 Wk Low
$158.92
Shares Out
7.55M
Yield
2.24%
Div. Freq
-
Avg. Volume Daily
60.36K
Beta
0.65
Avg. Expense Ratio
0.54%
P/B Ratio
3.61
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | High Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Jun 19, 2006 |
| Managers | Stan Ueland David G. McGarel Daniel J. Lindquist Roger F. Testin Erik Russo Chris A. Peterson Jon C. Erickson |
| Definition | This equity fund portfolio contains majority of stocks with strong financial performance and average growth potential |
Investment Policy
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved